홈
마켓
차트 & 아이디어
Algo
뉴스
스토어
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
히트맵
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
X
XPH
State Street SPDR S&P Pharmaceuticals ETF
58.0
9
USD
+0.76%
부문:
금융
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+0.76%
월간 변동
+0.36%
6달 변화
+2.07%
년간 변동율
+2.07%
이전 종가
57.6
5
Open
58.0
9
저가
57.9
7
High
58.0
9
양
5
마켓
US ETFs
XPH
전체 차트 열기
Full chart
개요
모든 보유 자산
히트맵
주요 보유 종목
Market Value
Shares
Weight %
RAPP
Rapport Therapeutics Inc
4.3 M
142.9 K
1.9%
Indivior PLC
4.3 M
120.9 K
1.9%
RPRX
Royalty Pharma PLC
4.3 M
112.0 K
1.9%
TARS
Tarsus Pharmaceuticals Inc
4.3 M
52.7 K
1.9%
PBH
Prestige Consumer Healthcare Inc
4.3 M
69.8 K
1.9%
Avadel Pharmaceuticals PLC
4.3 M
199.5 K
1.9%
JNJ
Johnson & Johnson
4.3 M
20.7 K
1.9%
OGN
Organon & Co
4.3 M
596.7 K
1.9%
PHAT
Phathom Pharmaceuticals Inc
4.2 M
253.9 K
1.8%
HROW
Harrow Inc
4.2 M
85.3 K
1.8%
INVA
Innoviva Inc
4.2 M
207.8 K
1.8%
CRNX
Crinetics Pharmaceuticals Inc
4.1 M
89.1 K
1.8%
ESPR
Esperion Therapeutics Inc
4.1 M
1.1 M
1.8%
PFE
Pfizer Inc
4.1 M
166.2 K
1.8%
ANIP
ANI Pharmaceuticals Inc
4.1 M
52.2 K
1.8%
HRMY
Harmony Biosciences Holdings Inc
4.1 M
109.1 K
1.8%
COLL
Collegium Pharmaceutical Inc
4.1 M
87.7 K
1.8%
MAZE
Maze Therapeutics Inc
4.0 M
96.1 K
1.7%
AMLX
Amylyx Pharmaceuticals Inc
3.9 M
323.8 K
1.7%
TERN
Terns Pharmaceuticals Inc
3.9 M
96.0 K
1.7%
1
2
3
뉴스
Seeking Innovation Beyond Tech? Insight On Healthcare Stocks
Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts
What's The Dominant Trend In Earnings: AI Or Geopolitics?
Medical Technology Stocks: Innovation Endures As Valuations Reset
Why Is Amneal Pharmaceuticals Stock Gaining Today? - Amneal Pharmaceuticals (NASDAQ:AMRX)
Defensive Stocks: A Potential Antidote To Inflation Shocks
AI And The Future Of Healthcare
Global PMI: Tracking The Sectors Hit Hardest By The Middle East War
Can Forgotten Biotech Break Out?
Concerns Shift From Obsolescence To Oil
CDT Insider Sentiment March 2026: The Probability Race And Barbell Strategies
Trump's 100% Pharma Tariffs Will Have A Limited Effect On The Sector